These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 11293642)
1. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U; Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092 [TBL] [Abstract][Full Text] [Related]
3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. EUROASPIRE II Study Group Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143 [TBL] [Abstract][Full Text] [Related]
4. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267 [TBL] [Abstract][Full Text] [Related]
5. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013. Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D; Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643 [TBL] [Abstract][Full Text] [Related]
6. Blood pressure is insufficiently controlled in European patients with established coronary heart disease. Boersma E; Keil U; De Bacquer D; De Backer G; Pyörälä K; Poldermans D; Leprotti C; Pilotto L; de Swart E; Deckers JW; Heidrich J; Sans S; Kotseva K; Wood D; Ambrosio GB; J Hypertens; 2003 Oct; 21(10):1831-40. PubMed ID: 14508188 [TBL] [Abstract][Full Text] [Related]
7. Potential for cholesterol lowering in secondary prevention of coronary heart disease in europe: findings from EUROASPIRE study. European Action on Secondary Prevention through Intervention to Reduce Events. Vanuzzo D; Pilotto L; Ambrosio GB; Pyörälä K; Lehto S; De Bacquer D; De Backer G; Wood D; Atherosclerosis; 2000 Dec; 153(2):505-17. PubMed ID: 11164441 [TBL] [Abstract][Full Text] [Related]
8. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D; Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158 [TBL] [Abstract][Full Text] [Related]
9. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U; Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307 [TBL] [Abstract][Full Text] [Related]
10. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109 [TBL] [Abstract][Full Text] [Related]
11. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology. Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624 [TBL] [Abstract][Full Text] [Related]
13. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Bowker TJ; Clayton TC; Ingham J; McLennan NR; Hobson HL; Pyke SD; Schofield B; Wood DA Heart; 1996 Apr; 75(4):334-42. PubMed ID: 8705756 [TBL] [Abstract][Full Text] [Related]
14. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys. Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766 [TBL] [Abstract][Full Text] [Related]
15. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys. Pyörälä K; Lehto S; De Bacquer D; De Sutter J; Sans S; Keil U; Wood D; De Backer G; Diabetologia; 2004 Jul; 47(7):1257-1265. PubMed ID: 15235774 [TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany]. Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058 [TBL] [Abstract][Full Text] [Related]
17. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys. Mayer O; Simon J; Rosolová H; De Bacquer D; Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341 [TBL] [Abstract][Full Text] [Related]
18. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey. Wagner M; Gelbrich G; Kircher J; Kotseva K; Wood D; Morbach C; Leyh R; Ertl G; Karmann W; Störk S; Heuschmann PU Int J Behav Med; 2018 Jun; 25(3):283-293. PubMed ID: 29086252 [TBL] [Abstract][Full Text] [Related]
19. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results]. Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978 [TBL] [Abstract][Full Text] [Related]
20. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. Reiner Ž; De Bacquer D; Kotseva K; Prugger C; De Backer G; Wood D; Atherosclerosis; 2013 Dec; 231(2):300-7. PubMed ID: 24267243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]